MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease.

Li-Li DaiShu-De LiYi-Cheng MaJun-Rui TangJun-Yan LvYuan-Qing ZhangYing-Lei MiaoYan-Qiong MaChun-Mei LiYi-You ChuKun-Hua WangLan-Qing MaCheng-Gang Zou

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

Our findings suggest that miR-30b represents not only a potential target for the treatment of insulin resistance, but also a non-invasive disease biomarker of NAFLD.

Keyphrases

insulin resistance
type diabetes
metabolic syndrome
high fat diet
polycystic ovary syndrome
combination therapy
human health
weight loss